Clinical Effectiveness of Lyme Vaccine: A Matched Case-Control Study
- PMID: 34409119
- PMCID: PMC8364756
- DOI: 10.1093/ofid/ofab142
Clinical Effectiveness of Lyme Vaccine: A Matched Case-Control Study
Abstract
We conducted a matched case-control study to assess the effectiveness of Lyme vaccine (LYMErix) as it was used in clinical practice. We found ≥3 doses to be 71% effective against Lyme disease. This is the first study to show that the Lyme vaccine is effective in a real-world setting.
Keywords: LYMErix; Lyme vaccine; postlicensure; vaccine effectiveness.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures

References
-
- Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000; 132:661–8. - PubMed
-
- Steere AC, Sikand Vk, Meurice f, et al. . Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein a with adjuvant. N Engl J Med 1998; 339:209–15. - PubMed